- Home
- Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml
Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml Substitute
Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml Substitute
Delpoclav Syrup 30 ml
by AYUR
₹1.86per tabletAdvent 228.5mg Syrup 60 ml
by Others
₹1.90per tabletBactoclav Dry Syrup 30 ml
by Others
₹1.91per tabletNovamox CV 228.5 mg Tangy Orange Paediatric Dry Syrup 30 ml
by Others
₹1.91per tabletMoxikind CV Dry Syrup 30 ml
by Others
₹1.92per tabletMoxiforce-CV Dry Syrup 30 ml
by Others
₹1.92per tabletAdvent 228.5 mg Tangy Orange Flavour Dry Syrup 30 ml
by Others
₹1.94per tabletMega CV 228.5 Dry Syrup 60 ml
by Others
₹1.94per tabletAugpen HS BID 3.3 gm Syrup 30 ml
by AYUR
₹1.94per tabletMega-CV 228.5 mg Dry Syrup 30 ml
by Others
₹1.94per tabletAugpen HS Bid Syrup 30 ml
by Others
₹1.94per tabletMoxclav BD 6.6 gm Syrup 30 ml
by Others
₹1.94per tabletClamox Bid Dry Syrup 30 ml
by Others
₹1.94per tabletAugpen HS BID 4.5 gm Syrup 30 ml
by Others
₹1.94per tabletIndclav Bid Oral Syrup 30 ml
by Others
₹1.94per tablet
Verified Ingredients and Effects
Composition:
AMOXYCILLIN-200MG + CLAVULANIC ACID-28.5MG
Uses:
<p>Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is used in the treatment of bacterial infections in children. The detailed uses of Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml are as follows:</p><ul><li><strong>Treating Bacterial Infections: </strong>Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml treats various bacterial infections in children, including respiratory tract infections and ear infections, with its antibiotic properties.</li><li><strong>Sinusitis Management:</strong> Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml helps to manage sinusitis by treating bacterial infections that cause sinus inflammation, alleviating symptoms like facial pain and congestion.</li><li><strong>Skin Infections: </strong>Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is used in treating skin and soft tissue infections by targeting and eliminating the bacteria that cause the infection.</li><li><strong>Urinary Tract Infections:</strong> Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is indicated for treating urinary tract infections (UTIs) by targeting the bacteria causing the infection, providing relief from symptoms, and supporting recovery.</li><li><strong>Dental Infections: </strong>Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is also used in the treatment of dental infections, including dental abscesses and oral infections, promoting healing and relieving pain.</li></ul>
Medicinal Benefits:
- Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is used in children to treat respiratory tract infections, ear infections, urinary tract infections, skin infections, and dental infections.
- Amoxicillin weakens and damages the bacterial cell wall, leading to bacterial death and stopping the spread of infection.
- Clavulanic acid blocks the beta-lactamase enzyme produced by certain bacteria, ensuring amoxicillin remains effective.
- It helps in quicker resolution of symptoms by effectively targeting and eliminating infection-causing bacteria.
- Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is effective against a wide range of bacterial infections, including both aerobic (oxygen-dependent) and anaerobic (non-oxygen-dependent) bacteria.
FAQs
Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is used to treat bacterial infections in children.
Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml contains amoxycillin and clavulanic acid. Amoxycillin works by inhibiting the formation of the bacterial cell wall (a protective covering) and causing damage to the bacterial cell wall. This eventually leads to the death of the bacterial cell and thus prevents the growth of bacterial infections. Clavulanic acid inhibits the beta-lactamase enzyme, which prevents bacteria from destroying the efficacy of amoxycillin.
No, Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is not used to treat viral infections. It is an antibiotic used only to treat bacterial infections.
No. As Moxtas CV Paediatric Dry Syrup 3.3 gm/30 ml is an antibiotic, it is advised to complete your child's entire course of treatment as prescribed. If the treatment is stopped abruptly, drug resistance may develop.
